Share
 
Title
Code
Session Type
Venue
Date Time
Organizer:

With increased access to HIV treatment, average CD4 counts of patients have risen dramatically, yet HIV programs worldwide continue to see a significant proportion of patients presenting to care with advanced disease (CD4 < 200). As a priority group in the latest WHO ART guidelines, these patients require prompt yet careful management to prevent or curb deadly opportunistic infections such as cryptococcal meningitis and tuberculosis and to successfully initiate antiretroviral therapy. Additionally, attrition in care amongst these patients remains a problem, making proper engagement and support key to successful long-term management. Immediate and informed action in these situations can save patient lives in both the short and long run, making an understanding of the risks and knowledge of the tools available absolutely necessary for providers and patients alike. This session will give healthcare providers, laboratorians, pharmacists, program planners and patients a better understanding of specific risks.

10:15
Title Slide
10:15
MOSA1801
Opening remarks: making advanced disease a priority
Meg Doherty, World Health Organization (WHO), Switzerland
Nathan Ford, World Health Organization, Switzerland
Slides
10:35
MOSA1802
The changing face of advanced disease
Eric Goemaere, Médecins Sans Frontières (MSF), South Africa
Slides
10:55
MOSA1803
Adapting tuberculosis care for advanced patients
Salome Charalambous, The Aurum Institute, South Africa
11:15
MOSA1804
Methods of Infection prevention in advanced HIV care
Francesca Conradie, Southern African HIV Clinicians Society, South Africa
Slides
11:35
MOSA1805
Integrating cryptococcal screening into HIV care: the Namibian story
Francina Kaindjee-Tjituka, Namibian Ministry of Health and Social Services, Namibia
Slides
11:55
MOSA1806
Cervical cancer and AIDS-related malignancies
Masangu Mulongo, Right to Care, South Africa
Slides
12:15
MOSA1807
Implementation research priorities: a PEPFAR perspective
Ray Chimatira, CDC and USAID – South Africa, South Africa
Ola Oladinyimbo, CDC and USAID – South Africa, South Africa
Slides